Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on: January 21,2025

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on:January 21,2025

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on: February 20,2025

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on:February 20,2025

Research highlights urgent need for greater awareness to aid early diagnosis of bone cancers in young people

Updated on: April 01,2025

Research highlights urgent need for greater awareness to aid early diagnosis of bone cancers in young people

Updated on:April 01,2025

Long-term yogurt consumption tied to decreased incidence of certain types of colorectal cancer

Updated on: March 27,2025

Long-term yogurt consumption tied to decreased incidence of certain types of colorectal cancer

Updated on:March 27,2025

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on: January 22,2025

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on:January 22,2025

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on: January 22,2025

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on:January 22,2025

MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds

Updated on: March 27,2025

MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds

Updated on:March 27,2025

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on: January 23,2025

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on:January 23,2025

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on: January 22,2025

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on:January 22,2025

Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

bySaarland UniversityCredit: CC0 Public DomainFor people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally cut their finger while

Updated on: December 18,2024

Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

bySaarland UniversityCredit: CC0 Public DomainFor people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally cut their finger while

Updated on:December 18,2024

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t

Updated on: January 23,2025

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t

Updated on:January 23,2025

Cancer diagnoses and deaths are declining in Appalachia but remain significantly higher compared to other US regions

Updated on: March 27,2025

Cancer diagnoses and deaths are declining in Appalachia but remain significantly higher compared to other US regions

Updated on:March 27,2025